Skip to content

Teladoc Health

US · TDOC #3241 by market cap Listed 2015
7.45 -0.34 -4.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:44

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 13 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.1 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
90.85% +6.14pp
Institutions
403 -13
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund65.18%
Hedge Fund17.84%
Public Company3.84%
Private Company2.05%
VC/PE Fund1.10%
Individual/Insider0.67%
Government Pension Fund0.47%
Insurance Company0.26%
Other8.53%

Top holders as of 2026-09-30

BlackRock 10.28% · 18.73M sh
Vanguard Portfolio Management, LLC 7.83% · 14.27M sh
American Century Investment Management 5.22% · 9.51M sh
Dimensional Fund Advisors 4.99% · 9.10M sh
Point72 Asset Management, L.P. 4.52% · 8.24M sh
Voss Capital, LP 4.41% · 8.05M sh
Renaissance Technologies Corp. 4.39% · 8.00M sh
Vanguard Capital Management, LLC 4.38% · 7.98M sh
State Street Global Advisors 2.71% · 4.94M sh
Pacific Investment Management Company LLC 2.56% · 4.67M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 13 buys · 34 sells

NameRoleStake
Charles Divita Chief Executive Officer 0.26%
David Snow Former Independent Non-Executive Director 0.09%
Mala Murthy Former Chief Financial Officer 0.08%
Adam Vandervoort Former Chief Legal Officer 0.06%
Kelly Bliss President of U.S. Group Health 0.05%
Catherine Jacobson Independent Director 0.04%
David Shedlarz Independent Director 0.03%
Sandra Fenwick Independent Director 0.02%
Carlos Nueno President of Global Health Systems 0.02%
Joseph Catapano Chief Accounting Officer 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 Carlos Nueno President of Global Health Systems Automatic Disposition -29,432 $9.20
2026-11-01 Jonathan Dorfman Chief Legal Officer Initial Statement of Beneficial 0 --
2026-10-01 Joseph Catapano Chief Accounting Officer Derivative Exercise and Sale -655 $5.65
2026-09-30 Joseph Catapano Chief Accounting Officer Derivative Exercise and Retained +1,428 --
2026-09-10 Charles Divita Chief Executive Officer Derivative Exercise and Sale -17,805 $6.10
2026-09-10 Charles Divita Chief Executive Officer Intent to Sell (Form 144) -17,805 $6.10
2026-09-09 Charles Divita Chief Executive Officer Derivative Exercise and Retained +24,997 --
2026-09-02 Fernando Madeira President of BetterHelp Derivative Exercise and Sale -15,251 $6.30–6.51
2026-09-02 Fernando Madeira President of BetterHelp Intent to Sell (Form 144) -9,812 $6.51
2026-09-01 Charles Divita Chief Executive Officer Derivative Exercise and Sale -18,327 $6.30
2026-09-01 Charles Divita Chief Executive Officer Intent to Sell (Form 144) -18,327 $6.30
2026-09-01 Joseph Catapano Chief Accounting Officer Derivative Exercise and Sale -274 $6.30
2026-09-01 Adam Vandervoort Former Chief Legal Officer Derivative Exercise and Sale -7,573 $6.30
2026-09-01 Adam Vandervoort Former Chief Legal Officer Intent to Sell (Form 144) -7,573 $6.30
2026-09-01 Fernando Madeira President of BetterHelp Intent to Sell (Form 144) -5,439 $6.30
2026-09-01 Kelly Bliss President of U.S. Group Health Derivative Exercise and Sale -7,357 $6.30
2026-09-01 Kelly Bliss President of U.S. Group Health Intent to Sell (Form 144) -7,357 $6.30
2026-09-01 Carlos Nueno President of Global Health Systems Derivative Exercise and Sale -6,200 $6.30
2026-09-01 Carlos Nueno President of Global Health Systems Intent to Sell (Form 144) -6,200 $6.30
2026-08-31 Charles Divita Chief Executive Officer Derivative Exercise and Retained +25,916 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:44:00 · For reference only, not investment advice and not tailored to your situation.

Teladoc Health discussion 0 comments

Add a comment